BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38104284)

  • 41. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.
    Jacobs G; Hellmig S; Huse K; Titz A; Franke A; Kwiatkowski R; Ott S; Kosmahl M; Fischbach W; Lucius R; Klapper W; Fölsch UR; Hampe J; Schreiber S; Rosenstiel P
    Haematologica; 2011 Jul; 96(7):987-95. PubMed ID: 21459793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines.
    Sicairos B; Alam S; Du Y
    BMC Cancer; 2023 May; 23(1):441. PubMed ID: 37189027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.
    Zhan Z; Wu J; Zhang JF; Yang YP; Tong S; Zhang CB; Li J; Yang XW; Dong W
    Mol Biol Rep; 2012 Aug; 39(8):8107-13. PubMed ID: 22535324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue.
    Celebiler Cavusoglu A; Sevinc AI; Saydam S; Canda T; Baskan Z; Kilic Y; Sakizli M
    Neoplasma; 2010; 57(5):465-72. PubMed ID: 20568901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
    Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
    Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
    Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
    Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
    Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.
    Ma YY; Wu WQ; Liu ZC; Yu XF; Guo K; He QW; Jiang SB; Shao QS; Tao HQ; Huang DS
    World J Surg Oncol; 2016 Jun; 14(1):169. PubMed ID: 27349965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The epithelial cadherin -160C/A polymorphism is associated with decreased risk of colorectal cancer: a case-control study.
    Li W; Xiao D; Wu H; Xu L
    Clin Exp Med; 2020 Feb; 20(1):73-78. PubMed ID: 31625007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-7/IL7R axis dysfunction in adults with severe community-acquired pneumonia (CAP): a cross-sectional study.
    Ampuero S; Bahamonde G; Tempio F; Garmendia ML; Ruiz M; Pizarro R; Rossi P; Huenchur L; Lizama L; López M; Avendaño LF; Luchsinger V
    Sci Rep; 2022 Jul; 12(1):13145. PubMed ID: 35907923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical spectrum and pleiotropic nature of
    Figueiredo J; Melo S; Carneiro P; Moreira AM; Fernandes MS; Ribeiro AS; Guilford P; Paredes J; Seruca R
    J Med Genet; 2019 Apr; 56(4):199-208. PubMed ID: 30661051
    [No Abstract]   [Full Text] [Related]  

  • 54. rs73092672 allele T is significantly associated with the higher risk of breast cancer incidence.
    Oroujalian A; Peymani M; Ghaedi K
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):779-789. PubMed ID: 34284702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
    Sombekke MH; van der Voort LF; Kragt JJ; Nielsen JM; Guzel H; Visser A; Oudejans CB; Crusius JB; Peña AS; Vrenken H; Polman CH; Killestein J
    Mult Scler; 2011 Aug; 17(8):922-30. PubMed ID: 21543551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
    Tabassum S; Munir F; Al Awadh AA; Anwar Z
    Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
    Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.